| 122.97 Net Asset Value | +0.83% 1 Day | +39.37% Year-to-Date | Overall Morningstar Rating |
| Health Style or Category | No Load Sales Expenses | 3.00% Expense Ratio | High Morningstar Risk Rating™ |
| 1 month | +11.82% | 3 years | +31.67% | |
| 3 months | +29.55% | 5 years | +20.34% | |
| 1 year | +85.31% | Since inception | +1.50% |
| BIPSX | Category | |
|---|---|---|
| Performance 5-yr return | +20.34% | +12.10% |
| Expense ratio | 3.00% | 1.55% |
| Risk 5 year sharpe ratio | 0.74 | 0.70 |
| Net assets | $167.7M | $1.5B |
| Average market cap | $24.7B | $16.2B |
| Average P/E | 22.6 | 21.1 |
| Portfolio turnover | 37% | 37% |
There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.
| Fund family | ProFunds |
| Fund manager & tenure | Hratch Najarian / 1 Years |
| Minimal initial investment | $15,000.00 |
| Minimum IRA investment | $15,000.00 |
| Other | 100.00% |
| U.S. stock | -- |
| International stock | -- |
| Fixed income | -- |
| Cash | -- |
| Healthcare | 100.00% |
| Business service | 0.00% |
| Consumer goods | 0.00% |
| Consumer service | 0.00% |
| Energy | 0.00% |
| AMGN Amgen Inc | 14.39% |
| GILD Gilead Sciences Inc | 10.98% |
| BIIB Biogen Idec Inc | 7.04% |
| CELG Celgene Corporation | 6.82% |
| ALXN Alexion Pharmaceuticals, Inc. | 3.75% |
| REGN Regeneron Pharmaceuticals, Inc. | 2.31% |
| VRTX Vertex Pharmaceuticals | 2.24% |
| LIFE Life Technologies Corp | 1.86% |
| ILMN Illumina, Inc. | 1.25% |
| ONXX Onyx Pharmaceuticals, Inc. | 1.10% |
.
